🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Looking forward to sharing our work further describing post-progression therapies and outcomes for BRCA-related pancreas cancer. Great work Baqir Jafry, MD #ASCO24 ASCO Salwan Al Mutar MD MS Kim Reiss Binder (Kim Reiss) Syed Kazmi, M.D.

Incredible to watch a once-a-lifetime Solar Eclipse in its totality!

Lunch with the UTSW Med Onc and Surg team! Thank you for organizing this Dr. Emina Huang UTSW Surgery! Had a great time with Syed Kazmi, M.D. and others! Missed Munir H Buhaya UTSW Simmons Cancer Center Aga Khan University

Thrilled to share our research on prognostic factors impacting NET survival, leveraging our institutional database UT Southwestern Medical Center, at the esteemed #SeldinSymposium2024 Thomas Wang, MD Profound thanks to my mentor Syed Kazmi, M.D. for his relentless guidance! UTSW Simmons Cancer Center Aga Khan University

Thrilled to lead the publication in #JNCC on efficacy of adj chemo in high/low-risk MSI-H/MSS colon cancers using the largest cohort! Immensely grateful for support of Syed Kazmi, M.D. Tim Brown, MD MSCE Amy Little Jones, MD Munir H Buhaya Nilesh Verma and others! tinyurl.com/2mrt6r2j

Our propensity score-matched, landmark analysis confirms that low & high-risk stage 2 MSI-H CRC shows a trend towards lower overall survival with adjuvant chemo while in stage 3 CRC, adjuvant chemo significantly improved survival regardless of MSI status and risk stratification

New review out now: "Advances in Immunooncology and Precision Medicine in Cholangiocarcinoma" thieme-connect.com/products/ejour…

En route to #Chicago for my first #ASCO24 conference! Excited to present my research, meet some of my favorite researchers, and connect with aspiring oncologists from around the globe. #OncologyResearch #ConquerCancer

I want to thank OncoDaily for inviting me to #OncoDailyParty last night. It was fantastic to meet oncology aspirants from around the world and witness leading oncologists making a difference in advancing cancer care at Yvonne Awards Pashtoon Kasi MD, MS Yelena Y. Janjigian MD Vivek Subbiah, MD

Head onto poster #136 where we are discussing about our study and poor clinical trials/post hoc analyses on outcomes of BRCA mutated metastatic pancreatic cancer patients who progress on PARP inhibitors Syed Kazmi, M.D. Tim Brown, MD MSCE Salwan Al Mutar MD MS Kim Reiss Binder (Kim Reiss)

15 Posts From ASCO 2024 Day 1 You Should Not Miss! Vivek Subbiah, MD Narjust Florez, MD, FASCO Stephen V Liu, MD Rachna Shroff, MD, MS, FASCO Arturo LoAIza-Bonilla, MD MSEd Haydeé Verduzco Eric K. Singhi, MD Sumanta K. Pal, MD, FASCO Cristiane D Bergerot Paolo Tarantino Yelena Y. Janjigian MD Herbert Loong, MBBS, FASCO Baqir Jafry, MD Dr Julia Lai-Kwon #ASCO24 oncodaily.com/societies/7588…

Baqir Jafry did an excellent job presenting real-world data in pancreatic cancer under the guidance of one of our most promising young faculty, Dr. Tim Brown.

Thank you so much, Hannah - 💜 🄴🄲🄷🄾 for the amazing feedback! A huge part of this credit goes to Tim Brown, MD MSCE for his excellent mentorship throughout the project. I truly appreciate the support!

Had a fantastic conversation with Charles Jiang MD, MPH about socio-economic disparities in healthcare and the role of real-world data in understanding their impact on healthcare outcomes and treatment decisions for various cancers. #ASCO24 #EarlyCareerOpportunities #OncologyResearch

Join us at #ASCOGU25 as we present our Merit Award-winning study on Medicare Advantage and its impact on timely treatment intensification in metastatic prostate cancer Charles Jiang MD, MPH Flatiron Health ASCO Conquer Cancer, the ASCO Foundation OncoDaily OncoAlert

Truly a memorable experience at #WVOS2025—had the honor of presenting our research, spending time with friends, and enjoying the beautiful setting of Stonewall Resort! Grateful for the chance to learn, grow and make memories CAMC Internal Medicine Residency Amna Anees MD FACP CAMC Institute for Academic Medicine

New data reinforces it: 📉 MA plans delay cancer care. In MSI-H mCRC MA patients were 42% less likely to get pembro within 90 days vs TM (OR  0.58 p<0.5) Flatiron Health Delays hit lower-SES patients hardest! Charles Jiang MD, MPH Tim Brown, MD MSCE Syed Kazmi, M.D. ASCO Amna Anees MD FACP

85% patients faced financial toxicity. 1 in 4 experienced catastrophic health expenditure. Low income = higher risk of FT. #ASCO24 #GlobalOncology #FinancialToxicity UW-Madison Department of Surgery Global Oncology | UWCCC Aga Khan University Dr Rizwan Khan AKU Surgery Adil Haider Syed Nabeel Zafar

Strong Aga Khan University representation ASCO 25! Syed Kazmi, M.D. Shaalan Beg MD MBA FASCO Maliha Nusrat Nausheen Ahmed MD Pashtoon Kasi MD, MS Sehar Salim Virani Shameel Shafqat MD and others!